Enterprise Value
$157.13 M
-$6.72 M-4.10%
Tue, 25 Feb 2025 23:04:11 GMT
Summary
- As of February 26, 2025, IKT enterprise value is $157.13 million, with a fall of -$6.72 million (-4.10%) during the most recent trading day.
- Over the past year, IKT enterprise value has increased by +$152.64 million (+3392.44%).
- IKT enterprise value is now -41.65% below its all-time high of $269.29 million.
Performance
IKT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
IKT Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -4.1% | -4.1% | -4.1% |
| 1 m1 month | -16.4% | -16.4% | -16.4% |
| 3 m3 months | +0.9% | +0.9% | +0.9% |
| 6 m6 months | +1885.5% | +1359.0% | +62.1% |
| ytdytd | -27.8% | -27.7% | -27.7% |
| 1 y1 year | +3392.4% | +1076.3% | +8.3% |
| 5 y5 years | - | - | - |
IKT Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -23.8% | $138 M | +14.2% | |
| 3 m | 3-month | $269 M | -41.6% | $138 M | +14.2% |
| 6 m | 6-month | $269 M | -41.6% | $5.68 M | +2668.9% |
| 1 y | 1-year | $269 M | -41.6% | $3.57 M | +4299.1% |
| 3 y | 3-year | $269 M | -41.6% | -$21 M | +858.4% |
| 5 y | 5-year | $269 M | -41.6% | -$21 M | +858.4% |
| alltime | all time | $269 M | -41.6% | -$21 M | +858.4% |
Inhibikase Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $157.13 M(-27.8%) |
| 2024 | $217.61 M(<-9900.0%) |
| 2023 | -$1.25 M(-121.7%) |
| Date | Value |
|---|---|
| 2022 | $5.78 M(-263.9%) |
| 2021 | -$3.52 M(-106.3%) |
| 2020 | $55.71 M |
FAQ
- What is Inhibikase Therapeutics enterprise value?
- What is the all time high enterprise value for Inhibikase Therapeutics?
- What is IKT enterprise value year-to-date change?
- What is Inhibikase Therapeutics enterprise value year-on-year change?
What is Inhibikase Therapeutics enterprise value?
The current enterprise value of IKT is $157.13 M
What is the all time high enterprise value for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high enterprise value is $269.29 M
What is IKT enterprise value year-to-date change?
Inhibikase Therapeutics enterprise value has changed by -$60.47 M (-27.79%) since the beginning of the year
What is Inhibikase Therapeutics enterprise value year-on-year change?
Over the past year, IKT enterprise value has changed by +$152.64 M (+3392.44%)